[1] BRUNIERA F R, FERREIRA F M, SAVIOLLI L R, et al. The use of vancomycin with its therapeutic and adverse effects: a review[J]. Eur Rev Med Pharmacol Sci,2015,19(4):694-700.
[2] BLACK E, LAU T T, ENSOM M H. Vancomycin-induced neutropenia: is it dose- or duration-related? Ann Pharmacother,2011,45(5):629-638. doi:  10.1345/aph.1P583
[3] SHAHAR A, BERNER Y, LEVI S. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime[J]. Ann Pharmacother,2000,34(2):263-264. doi:  10.1345/aph.19051
[4] 张金红, 房德敏, 高颖, 等. 万古霉素致血小板减少症的国内外文献系统回顾性分析[J]. 中国药学杂志, 2017, 52(21):1953-1960.
[5]

CARMICHAEL A J, AL-ZAHAWI M F. Drug points: Pancytopenia associated with vancomycin[J]. BMJ,1986,293(6554):1103.
[6]

ROCHA J L, KONDO W, BAPTISTA M I, et al. Uncommon vancomycin-induced side effects[J]. Braz J Infect Dis,2002,6(4):196-200. doi:  10.1590/S1413-86702002000400007
[7]

GUPTA S, SHARMA S, MENON N, et al. Case report of vancomycin-induced pancytopenia[J]. Rev Soc Bras Med Trop,2016,49(2):258-259. doi:  10.1590/0037-8682-0263-2015
[8]

LENG B, YAN G, LI T, et al. Vancomycin-induced reversible pancytopenia and rash in a 16-month-old boy with osteomyelitis: a case report? Int J Clin Pharmacol Ther,2020,58(4):242-246. doi:  10.5414/CP203619
[9] 中国腹膜透析相关感染防治专家组. 腹膜透析相关感染的防治指南[J]. 中华肾脏病杂志, 2018, 34(2):139-148. doi:  10.3760/cma.j.issn.1001-7097.2018.02.010
[10]

LI PK, SZETO CC, PIRAINO B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int,2018,38(4):313. doi:  10.3747/pdi.2018.00030
[11] 中国医药教育协会感染疾病专业委员会. 抗菌药物药代动力学/药效学理论临床应用专家共识[J]. 中华结核和呼吸杂志, 2018, 41(6):409-446. doi:  10.3760/cma.j.issn.1001-0939.2018.06.004
[12] 万古霉素临床应用剂量专家组. 万古霉素临床应用剂量中国专家共识[J]. 中华传染病杂志, 2012, 30(11):641-646. doi:  10.3760/cma.j.issn.1000-6680.2012.11.001
[13] 万古霉素临床应用中国专家共识(2011版)[J]. 万古霉素临床应用中国专家共识(2011版)[J]. 中国新药与临床杂志, 2011, 30(8):561-573.
[14] 翟所迪, 贺蓓, 王睿, 等. 《中国万古霉素治疗药物监测指南》解读[J]. 中国临床药理学杂志, 2016, 32(17):1633-1636.
[15] 国家药典委员会. 中华人民共和国药典: 临床用药须知(中药卷)(2005年版)[M]. 北京: 人民卫生出版社, 2005.
[16]

VON DRYGALSKI A, CURTIS B R, BOUGIE D W, et al. Vancomycin-induced immune thrombocytopenia[J]. N Engl J Med,2007,356(9):904-910. doi:  10.1056/NEJMoa065066
[17]

SCHWARTZ M D. Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody[J]. Pharmacother: J Hum Pharmacol Drug Ther,2002,22(6):783-788. doi:  10.1592/phco.22.9.783.34059